Delivery Order 36F79718D0355-36C25018F3143

<p>The Defense Logistics Agency issued a $56,503.68 delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for Ultomiris (pegloticase) 1,100 mg/11 ml vial pharmaceutical supply, with ultimate completion on January 29, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA.</p>

The Defense Logistics Agency awarded a $19,873 delivery order to DMS Pharmaceutical Group Inc. to supply 4561806823 SOLIRIS 300 MG/30 ML VIAL 30ML. The firm fixed price order is being funded by the Defense Logistics Agency and will be performed in Park Ridge, Illinois with work scheduled to be completed by August 29, 2023. SOLIRIS is a therapeutic medication used to treat certain rare diseases. This small order for SOLIRIS vials supports the Defense Logistics Agency's mission to provide...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Ultomiris (pecirilumab) 300 mg/3 mL vials, with a ceiling value of $56,503.48 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 4, 2026. No set-aside was applied. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...

This firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to DMS Pharmaceutical Group Inc. for the supply of 4562177887 SOLIRIS 300 MG/30 ML VIAL 30ML. The contract value is $39,746 and requires delivery to a location in Park Ridge, Illinois between September 11 and October 2, 2023. DLA supports the medical readiness of armed forces through procurement and distribution of pharmaceuticals, medical supplies, and equipment. SOLIRIS is a...

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $40,058.24 firm-fixed-price contract is for the delivery of Soliris (300 mg/30 ml vial) with a completion date of March 5, 2024. DMS Pharmaceutical Group Inc. holds a separate $4,999,999 indefinite delivery contract (4600082013) with the DLA under the SPE2DB program, which enables the agency to issue...

This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,746.00 contract is for the delivery of SOLIRIS 300 MG/30 ML VIAL 30ML, a specialty pharmaceutical product, with a period of performance through September 13, 2023. The award is part of DMS Pharmaceutical Group's larger $499,999,999 Indefinite...

The Defense Logistics Agency issued a $28,251.81 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for Ultomiris (periphreral) 1,100 mg/11 ml vial pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 20, 2026. No set-aside was used. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on...

<p>The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on May 20, 2026, for Ultomiris 1,100 mg/11 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of June 11, 2026. No set-aside was used. The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to Defense Health Agency and military medical facilities.</p>

<p>The Defense Logistics Agency issued a $28,251.84 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 mL vials under firm fixed-price terms.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 15, 2026. No set-aside applies to this order.</p>

The Defense Logistics Agency awarded a $59,619 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 30 vials of the drug Soliris (eculizumab) for intravenous administration. The place of performance is in Park Ridge, Illinois, with deliveries required between September 5-26, 2023. No subcontractors or set aside designations were identified. The DLA manages the Department of Defense's global supply chain and distribution network, procuring billions of dollars' worth of...